{"name":"Korea Otsuka Pharmaceutical Co., Ltd.","slug":"korea-otsuka-pharmaceutical-co-ltd","ticker":"","exchange":"","domain":"koreaotsuka.com","description":"Korea Otsuka Pharmaceutical Co., Ltd. is a subsidiary of Otsuka Pharmaceutical, focusing on the research, development, and commercialization of pharmaceutical products in South Korea. The company has a diverse portfolio of marketed drugs and a pipeline that includes several compounds in various stages of clinical development.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"Mucosta Tab.","genericName":"Mucosta Tab.","slug":"mucosta-tab","indication":"Other","status":"marketed"},{"name":"Aripiprazole, Solian, Olanzapine, Seroquel, Risperidone","genericName":"Aripiprazole, Solian, Olanzapine, Seroquel, Risperidone","slug":"aripiprazole-solian-olanzapine-seroquel-risperidone","indication":"Other","status":"marketed"},{"name":"Pletaal SR capsule","genericName":"Pletaal SR capsule","slug":"pletaal-sr-capsule","indication":"Intermittent claudication due to peripheral arterial disease","status":"marketed"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Depakote (divalproate)","genericName":"Depakote (divalproate)","slug":"depakote-divalproate","indication":"Epilepsy (seizure disorders)","status":"marketed"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"MCT-SR","genericName":"MCT-SR","slug":"mct-sr","indication":"Nutritional support in malabsorption disorders","status":"phase_3"}]}],"pipeline":[{"name":"Mucosta Tab.","genericName":"Mucosta Tab.","slug":"mucosta-tab","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Aripiprazole, Solian, Olanzapine, Seroquel, Risperidone","genericName":"Aripiprazole, Solian, Olanzapine, Seroquel, Risperidone","slug":"aripiprazole-solian-olanzapine-seroquel-risperidone","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Depakote (divalproate)","genericName":"Depakote (divalproate)","slug":"depakote-divalproate","phase":"marketed","mechanism":"Divalproate increases brain GABA levels and inhibits histone deacetylase, enhancing inhibitory neurotransmission and altering gene expression.","indications":["Epilepsy (seizure disorders)","Bipolar disorder (acute mania)","Migraine prophylaxis"],"catalyst":""},{"name":"MCT-SR","genericName":"MCT-SR","slug":"mct-sr","phase":"phase_3","mechanism":"MCT-SR is a sustained-release formulation of medium-chain triglycerides designed to improve lipid absorption and nutritional support.","indications":["Nutritional support in malabsorption disorders","Lipid supplementation in patients with impaired fat digestion"],"catalyst":""},{"name":"Pletaal SR capsule","genericName":"Pletaal SR capsule","slug":"pletaal-sr-capsule","phase":"marketed","mechanism":"Cilostazol inhibits phosphodiesterase-3 (PDE-3) to increase cAMP levels, promoting vasodilation and inhibiting platelet aggregation.","indications":["Intermittent claudication due to peripheral arterial disease"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE1STHl5aTlPd3ZtWVZfNThGRnA5ZUtVZmIxNzc2bEI5MUNLUUZkRnpjRHZnYTJOOGt2UkRBVzBSNHJzNnhlZnRVWDBZSzlXUS1FLXdGRWtfV2x1MkttVmNUM2RCcnAya3dSbGYzZkJSa3pvZTJMSHpRSg?oc=5","date":"2026-02-12","type":"regulatory","source":"otsuka.co.jp","summary":"Opening Egypt's First ORONAMIN C DRINK Factory Meeting Growing Demand and Contributing to Community Health - otsuka.co.jp","headline":"Opening Egypt's First ORONAMIN C DRINK Factory Meeting Growing Demand and Contributing to Community Health","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxOTHdnOEl1a3AyeXJlSUlERFM4dEdZMU1VU2c2ZHFXNVJuWlB1ZDhKY3ZpcENlbEx3YVdFdnVkV2VxOWNTdGZ6b3VKMXpwQU82R2dqdDRvdkdKYkZzNElzYXJoOVhIc25Rbzg2SzVCNl9SQV9ieVpveDFXY2prSXkzaGhDblhpZWNWaGtteUMxU3RQQ09tSmJRV3Aya0J2TG95ck9NRVlnYXMzY1BXeERWMWNJbk00ZkRxN2VOQ0RRMFBBNjJ2bnhSSy1qQQ?oc=5","date":"2026-02-06","type":"pipeline","source":"BioSpectrum Asia","summary":"Sky Labs inks distribution agreement with Otsuka Pharma for 'CART BP pro' in Japan - BioSpectrum Asia","headline":"Sky Labs inks distribution agreement with Otsuka Pharma for 'CART BP pro' in Japan","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxNckgxS1p5WV9fVWVHc2hMMldDTXJDNHM5aUtzWlFoazlvczE5NFRzTDlJSzU3eVBQUnM4X3Y0TWk4dTBkZlkySmUtZERyUXJCdjRPNl84M3hTdlNvQl9EYTFhWkV1a1RqTzdpRFdrRFVJQzVacmYyMzRZSlVVbUd4dUIzTjJoV3ZpRkUxUXVkRjN0MS03d1pvODlNVmFUcm9NcW5QdDBUNkFfY2xUVHQ2b2hYdDEwdW5YY1A2OENBWFFXOTdOdEUtTHBWclR0R3BpMEx2NWp6UEt3QlRJTXd3aF9CcWJyVnI1eC1n?oc=5","date":"2026-02-05","type":"pipeline","source":"PR Newswire","summary":"Sky Labs Signs Exclusive Distribution Agreement with Otsuka Pharmaceutical for 'CART BP pro' in Japan - PR Newswire","headline":"Sky Labs Signs Exclusive Distribution Agreement with Otsuka Pharmaceutical for 'CART BP pro' in Japan","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxNNEVDOUJxeDgteS04QjZocU8ycW9wNEd2cmkyRWZHZzdJLTVCVVlnai1ZMHAtTWpMZXN3bmxnbG9NOTVvc0RUMFRET0pvR3pvWlpSM1JxQnJ6Wng4bzdOa21yVzllVmY5N0N0UXFFQTB0TzlIQnpJZ3pxT3Y4RXFGNVNYWVE3eVRsWnk5NVVrU0xITW1QMFVwSkwzQjZpa1llTl9WWjhFMzNuSDEwM3ZsTWxRV1BLNnZTY05hUm1JTDZmUnVwWlJpd0JJV2M?oc=5","date":"2026-01-27","type":"deal","source":"BioSpectrum Asia","summary":"Japan's Otsuka and Towa form strategic partnership in pharmaceutical manufacturing - BioSpectrum Asia","headline":"Japan's Otsuka and Towa form strategic partnership in pharmaceutical manufacturing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxPUlllUS10QkR5bi1XWF9IaWZaTVlmVGpPQ1c3YndWS1ViR2hOTWFXajdyNmJUWVR3R1E3MlF5bXFuV0dyOTRnMmxsbjQwX3N1UlIxXzROVFhIaVFiNFl6SnZ4bENxSlVFMXo5QURoNm5RZXhpdXd1Y2g5X3NfNlJ1YV9sY1lRMVBDQ0l6WF9rQUI1UU1QbjRtV3NtTDBMcXIxWGFlN092U3d0NUJXRi1seUp5RWdBN3ZZRUc4cTVYSjlWMnBqRkxWaVpqY09EVEU?oc=5","date":"2025-09-26","type":"pipeline","source":"The Straits Times","summary":"Trump’s pharma tariffs threaten future investments even as immediate impact to S’pore seen as mild - The Straits Times","headline":"Trump’s pharma tariffs threaten future investments even as immediate impact to S’pore seen as mild","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxNTERJZ25jc1NPd3BYMzBNc3k1RUttSWdxNUVVUzRiUVNtZUJjTGljTTNEN0lLNkItQklPeWx4cWJWS29wSXpuWXZzSFkydE05eVVmamJna2RHaEFONHRMTld6MGoxTlZJcWNmdFUyMFA4aU5UbVJnalM1NDMyT0VUSk40MHlDTm1kdXE4SXZ2ZkNWcmZmU0xBM3I2Wm9nYTBlNjlGMEtIQVZ5aWhpYnc?oc=5","date":"2025-07-18","type":"deal","source":"Fierce Pharma","summary":"Fierce Pharma Asia—China biotech deal boom; Takeda's narcolepsy win; Sino Biopharm's LaNova buyout - Fierce Pharma","headline":"Fierce Pharma Asia—China biotech deal boom; Takeda's narcolepsy win; Sino Biopharm's LaNova buyout","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxOZWphd2RQSUN6amxjQnU4TE9KVHYzYmp1Q1ZBaXhvUUJDU2NEdHZuSU1GOFZjZlZvTnNkS0pab3ZrWUpSaGJsWEdPUjQxLTh3aDQxOEo4T0o2bmFFSDdXWXRCLVptTFY1NUdJUmtrOGN0V1MtM3pUTURPVHhRc0FsTHF0RXM?oc=5","date":"2025-05-28","type":"trial","source":"Market Data Forecast","summary":"Asia Pacific Insomnia Market Size, Share & Analysis, 2033 - Market Data Forecast","headline":"Asia Pacific Insomnia Market Size, Share & Analysis, 2033","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBHaUwteHZ4STgxaEpMWWRKT3I2ZE1sSFRMZWJYdm1aUG1TS3VVbFBxWUZKV05xRHBxRzc0U25WLURIVVZyZFdfaHUzYlV6Ym5KMDdaWUh4NXpRQlUzOWFB?oc=5","date":"2025-02-17","type":"trial","source":"Nature","summary":"Improved prognosis of advanced-stage extranodal NK/T-cell lymphoma: results of the NKEA-Next study | Leukemia - Nature","headline":"Improved prognosis of advanced-stage extranodal NK/T-cell lymphoma: results of the NKEA-Next study | Leukemia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE5jcHRid01JZnR5YU1SLWFWd0ZKSm5ETVhBc2d6LXlXV1hJZlJUc1U4ZWdSSXkxVVFvRUhDYzFxci1VeWVBbzhPem52bEdnRGEyOFU3Z3ZxV2lJRjB3NUZuUzZKcE85aDRTM2JkMm9TRUFkdHB4c3ZRMQ?oc=5","date":"2024-06-10","type":"pipeline","source":"otsuka.co.jp","summary":"Korea Otsuka Pharmaceutical Launches Soy Bar \"SOYJOY\" Introducing a New Concept of Healthy Snacking - otsuka.co.jp","headline":"Korea Otsuka Pharmaceutical Launches Soy Bar \"SOYJOY\" Introducing a New Concept of Healthy Snacking","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5GaG50VUpkRzZSazF0V1QtMGd3X0h4M190RUhUNkVVamhHbk1mMG9sLW9IZk0wVkg3cUlVUjRtUUpFbTZpQ2EtOWtxcEE5eVZpSHNxV3A2MFFtZTR3V0J2MmF1bWpCd3BvajRjMTd3?oc=5","date":"2024-05-08","type":"regulatory","source":"Straits Research","summary":"Gastroparesis Drugs Market Size, Share, Trends & Demand 2033 - Straits Research","headline":"Gastroparesis Drugs Market Size, Share, Trends & Demand 2033","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNOUFJTF9pQjZkZHlEZm9lLS1NcnQ2eGRqbUhPMXVsalpHUHlLWGxFQWc0SEpDZ1hNQTVKODVKV2pEc3hwQ1FUS051NFhvbWF2LWQ2Ny1oTzh2clJLcFgzdGdhcF9LWDltLURfWWxpRE4wTm0xQ0UyWGNZcjVtT21vclY4R3Y2X3RvSXBsSVhxM29BTjQ3YllGMlpwN0V4a3J2ZlE0Mk5Da2U?oc=5","date":"2024-01-30","type":"deal","source":"BioWorld News","summary":"Travere licenses out rare kidney disease drug to Renalys in Asia - BioWorld News","headline":"Travere licenses out rare kidney disease drug to Renalys in Asia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE9ZM1duUDhHb09hdVVITHNLWDIwcWFwMEJ6U08yUDctR1JuSUJqQnRaZE5LRnN1dF8zeHp0a1RST1loT3o2R0xScUNnYzRMdWdoOHVpWVdwVlJ6Qkd2NkRnN0ZVaUhWR3oyNmhQU9IBcEFVX3lxTFA2aXIwRngzTUxUczA3SFZjc3k1VzlrTXRTbVA2TWRVQmpPUVN4bTV5NklacDF4QUZLdzdfTEVxaVJqNkx0eG5XeEpVRExuclpWUE5tRmdJZURKdWFsWjl6M1FEVVhiaVNySkgzdWk0QWo?oc=5","date":"2019-07-15","type":"pipeline","source":"koreabiomed.com","summary":"Self-claimed Korea Otsuka employee causes stir on far-right website - koreabiomed.com","headline":"Self-claimed Korea Otsuka employee causes stir on far-right website","sentiment":"neutral"}],"patents":[],"drugCount":5,"phaseCounts":{"marketed":4,"phase_3":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}